237 related articles for article (PubMed ID: 17869424)
1. Validation of the S-LANSS in the community setting.
Weingarten TN; Watson JC; Hooten WM; Wollan PC; Melton LJ; Locketz AJ; Wong GY; Yawn BP
Pain; 2007 Nov; 132(1-2):189-94. PubMed ID: 17869424
[TBL] [Abstract][Full Text] [Related]
2. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
Bennett MI; Smith BH; Torrance N; Potter J
J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
[TBL] [Abstract][Full Text] [Related]
3. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
Koc R; Erdemoglu AK
Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
[TBL] [Abstract][Full Text] [Related]
4. Can chronic neuropathic pain following thoracic surgery be predicted during the postoperative period?
Searle RD; Simpson MP; Simpson KH; Milton R; Bennett MI
Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):999-1002. PubMed ID: 19767301
[TBL] [Abstract][Full Text] [Related]
5. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.
Walsh J; Rabey MI; Hall TM
J Manipulative Physiol Ther; 2012; 35(3):196-202. PubMed ID: 22397741
[TBL] [Abstract][Full Text] [Related]
6. Linguistic adaptation, validation and comparison of 3 routinely used neuropathic pain questionnaires.
Li J; Feng Y; Han J; Fan B; Wu D; Zhang D; Du D; Li H; Lim J; Wang J; Jin Y; Fu Z
Pain Physician; 2012; 15(2):179-86. PubMed ID: 22430656
[TBL] [Abstract][Full Text] [Related]
7. Brazilian Portuguese validation of the Leeds Assessment of Neuropathic Symptoms and Signs for patients with chronic pain.
Schestatsky P; Félix-Torres V; Chaves ML; Câmara-Ehlers B; Mucenic T; Caumo W; Nascimento O; Bennett MI
Pain Med; 2011 Oct; 12(10):1544-50. PubMed ID: 21883875
[TBL] [Abstract][Full Text] [Related]
8. Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.
Elzahaf RA; Tashani OA; Unsworth BA; Johnson MI
Pain Pract; 2013 Mar; 13(3):198-205. PubMed ID: 22726274
[TBL] [Abstract][Full Text] [Related]
9. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
Cho SI; Lee CH; Park GH; Park CW; Kim HO
J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
[TBL] [Abstract][Full Text] [Related]
10. A neuropathic pain component is common in acute whiplash and associated with a more complex clinical presentation.
Sterling M; Pedler A
Man Ther; 2009 Apr; 14(2):173-9. PubMed ID: 18358761
[TBL] [Abstract][Full Text] [Related]
11. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community.
Smith BH; Torrance N; Bennett MI; Lee AJ
Clin J Pain; 2007 Feb; 23(2):143-9. PubMed ID: 17237663
[TBL] [Abstract][Full Text] [Related]
12. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.
Hamdan A; Luna JD; Del Pozo E; Gálvez R
Eur J Pain; 2014 Jan; 18(1):101-9. PubMed ID: 23776139
[TBL] [Abstract][Full Text] [Related]
15. Results of the Leeds assessment of neuropathic symptoms and signs pain scale in Turkey: a validation study.
Yucel A; Senocak M; Kocasoy Orhan E; Cimen A; Ertas M
J Pain; 2004 Oct; 5(8):427-32. PubMed ID: 15501424
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of neuropathic pain among patients suffering from chronic low back pain in Saudi Arabia.
Hassan AE; Saleh HA; Baroudy YM; Abdul-Rahman KI; Najjar MW; Kazi MS; El-Gazar MA; Hafez MA; Abdullah MA; Abdul-Rahman YA; Youseif EA
Saudi Med J; 2004 Dec; 25(12):1986-90. PubMed ID: 15711681
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4.
Unal-Cevik I; Sarioglu-Ay S; Evcik D
J Pain; 2010 Nov; 11(11):1129-35. PubMed ID: 20418179
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
[TBL] [Abstract][Full Text] [Related]
19. Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain?
Pamuk ON; Yeşil Y; Cakir N
Semin Arthritis Rheum; 2006 Oct; 36(2):130-4. PubMed ID: 16884973
[TBL] [Abstract][Full Text] [Related]
20. Relationship between pain and neuropathic symptoms in chronic musculoskeletal pain.
Giske L; Bautz-Holter E; Sandvik L; Røe C
Pain Med; 2009; 10(5):910-7. PubMed ID: 19453955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
